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Protein glycosylation is a common posttranslational 
modification that produces glycoproteins that are highly 
complex in terms of both their structure and in their 
function. Systematic structure-function studies of such 
glycoproteins require synthetic methods that can 
produce homogeneous glycoproteins with defined 
oligosaccharide sidechains. 
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The ubiquity of protein glycosylation is well established: 
glycoproteins are widely distributed in eukaryotic cells and 
may also be found in prokaryotes. The best characterized 
examples of protein-oligosaccharide bonds in glycoproteins 
are (i) N-glycosidic linkages between N-acetylglucosamine 
at the reducing end of an oligosaccharide chain and certain 
asparagines in the sequence Asn-X-Ser/Thr, and (ii) O-gly- 
cosidic linkages between a reducing N-acetylgalactosamine 
and certain serine or threonine residues. Three examples of 
the wide range of oligosaccharide chains typically associated 
with N-glycosidic linkages are illustrated in Figure 1. Com- 
bining biosynthetic pathways of glycosylation with chemi- 
cal synthesis can provide homogeneous preparations of 
glycoproteins for structure-function studies and, perhaps, 
for the clinic. 
Biosynthesis 
The biosynthesis of glycoproteins is well documented and 
is similar in all eukaryotes. For example, N-glycosylation is 
known to be concurrent with synthesis of the nascent 
polypeptide chain into the endoplasmic reticulum, where 
a common oligosaccharide precursor is transferred from a 
glycolipid to the nascent protein. Modification of this 
oligosaccharide precursor also occurs in the endoplasmic 
reticulum before the protein is transported to the Golgi 
apparatus for further modification by the host cell’s com- 
plement of glycosidases and glycosyltransferases. Each 
organism has its own ‘glycosylation machinery’ and thus 
expression of the same gene in different organisms pro- 
duces different glycoproteins. Moreover, the efficiency of 
one or more biosynthetic steps may be low, resulting in a 
mixture of oligosaccharide sidechains of different length 
and composition at each glycosylation site. Therefore a 
glycoprotein is generally a heterogeneous mixture of 
‘glycoforms’; protein molecules which differ only in the 
structure of the bound oligosaccharide. 
The functional role of oligosaccharides in glycoproteins 
The reason for the heterogeneity of protein glycosylation 
is still not well understood. But how much do the oligosac- 
charide chains influence the properties of glycoproteins? 
It is now established that the different glycoforms of a 
protein can have a range of different physical, biochemical 
and biological properties [l]. Thus, the heterogeneous 
glycosylations seem to constitute a subtle and sophisti- 
cated mechanism of biological control. Regulatory authori- 
ties in the United States have recognized the significance 
of such glycoforms in the case of tissue plasminogen acti- 
vator, a recombinant fibrinolytic agent. The glycoforms 
have been shown to have differing fibrin-dependent plas- 
minogenolytic activities [Z], and the United States Patent 
Office has therefore ruled that particular glycoforms must 
be specified in patents, even though all forms have the 
same amino-acid sequence. 
The most obvious way to determine the importance of an 
oligosaccharide chain is to remove it. Fully deglycosylated 
proteins can be prepared either by site-directed mutagen- 
esis of the gene to remove the glycosylation sites or by 
chemical and enzymatic deglycosylation of the protein. 
Partial deglycosylation of the protein can be achieved 
using glycosidases. Comparison of the structure and activ- 
ity of this range of different proteins suggests that the bio- 
logical roles of oligosaccharides vary from those that are 
seemingly trivial to those that are crucial for the develop- 
ment, growth, function and survival of the organism [3]. 
These roles include: (i) increasing the stability of the gly- 
coprotein to heat or proteolysis, (ii) modulating cell-cell 
interactions, (iii) altering protein-protein interactions, (iv) 
modulating biological activity and (v) targeting of the 
protein to particular sites within the cell or organism. 
Removing the oligosaccharide chains completely is a 
rather crude way to assess their function, however. There 
have been relatively few studies so far that have compared 
different homogeneous glycoforms of a glycoprotein. One 
recent example is that of bovine pancreatic ribonuclease, 
which has been isolated as five electrophoretically pure 
glycoforms; these molecules have a four-fold variation in 
enzymatic activity towards double-stranded RNA [4]. 
A dramatic recent demonstration of the importance of 
complex or hybrid N-glycosylation of glycoproteins in aivo 
came from studies of a mouse N-acetylglucosaminyltrans- 
ferase gene (Mgat-0 [S]. This transferase initiates the for- 
mation of complex and hybrid N-linked carbohydrates 
(Fig. l), and mouse embryos lacking the Mgat-I gene die 
at mid-gestation. Thus, the presence of these N-linked 
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Figure 1 
Mmal+2 
Three major subgroups of mammalian N-linked oligosaccharides. From 
the top the structures are complex-type, high mannose-type and 
hybrid-type. The structure within the large shaded box is common to all 
N-linked oligosaccharides. The structure within the small shaded box is 
the common core of the majority of high mannose oligosaccharides. 
Outside these lines the structures are variable. Adapted from [181. 
carbohydrates is essential, and lack of them is lethal at a 
very early stage of development. 
So far then, the only thing we can say with certainty about 
the role of oligosaccharides is that they mediate specific 
recognition events or modulate biological processes 131. 
The presence of oligosaccharides expands the possibilities 
for specific recognition far beyond those allowed by the 
limited number of proteins encoded in the genome of an 
organism [3].The functional diversity thus generated is 
crucial for the evolution and development of an organism. 
How can we understand glycoproteins better? 
To understand the relationship between oligosaccharide 
structure and glycoprotein function, homogeneous glyco- 
proteins containing oligosaccharide sidechains of defined 
structure must be obtained either by isolation from glyco- 
protein mixtures or by de ~O~JO synthesis. Chromato- 
graphic methods, in particular capillary electrophoresis 
[4], can now give access to pure glycoforms, but such 
methods are limited to glycoforms that are naturally avail- 
able and abundant. Synthetic approaches, however, can 
produce a much wider range of both natural and unnat- 
ural glycoproteins. The resultant synthetic glycoproteins 
can have better physical stability than the natural form, 
or, in the case of therapeutic glycoproteins, may show 
reduced toxicity and desirable pharmacokinetic and 
pharmacodynamic properties. 
The complex structure of the glycoproteins themselves 
and the complexity of the biosynthetic pathways make 
either chemical or biological synthesis of glycoproteins a 
formidable task. Nonetheless, some significant advances 
using both biological and chemical methodologies have 
been made in recent years, including glycosylation engi- 
neering, enzymatic synthesis and chemical synthesis, 
which are discussed below. 
Glycosylation engineering 
The concept of ‘glycosylation engineering’, that is, the 
manipulation of protein oligosaccharide sidechains by 
expression of genes in different hosts, has been discussed 
by Stanley [6]. Since each organism or cell has its own 
complement of glycosylation enzymes, glycosylation pat- 
terns will be biased in a predictable way. For example, 
when a gene is expressed in yeast, the resulting glycopro- 
tein has highly mannosylated oligosaccharides, whereas 
when the same gene is expressed in most mammalian cell 
lines, the product is a glycoprotein with diverse complex 
oligosaccharides capped with sialic acids and galactosides 
(see Fig. 1). This approach can be extended by using 
mutant cell lines in which the biosynthetic pathways have 
been interrupted; the products of such cells are biosyn- 
thetic intermediates of the glycosylation pathway, contain- 
ing truncated oligosaccharide sidechains. Interruption of 
the biosynthetic pathway can also be achieved by 
inhibitors such as tunicamycin, which prevents all 
asparagine-linked glycosylation. 
Mutant cell lines can also be produced by adding key gly- 
cosyltransferases to the complement of a cell’s glycosida- 
tion enzymes. This has already been successful with 
several glycosyltransferases, such as the addition of (~‘2-6 
sialyl transferase to a Chinese hamster ovary cell line [7]. 
But all such in ai~o approaches have the disadvantage that 
their products are heterogeneous. Thus, if we wish to 
study homogeneous (or unnatural) glycoproteins, we must 
turn to in vitro methods. 
Enzymatic synthesis of glycoproteins 
Glycosidases and glycosyltransferases are not only integral 
to in viva glycosylation, but are also useful for in V&O pro- 
cessing. A range of these enzymes has been made available 
through isolation from natural sources or by heterologous 
overexpression in foreign hosts; these enzymes have been 
shown to accept saccharides, glycolipids and glycoproteins 
as substrates. By using an excess of enzyme, high yielding 
reactions are possible, even with poor substrates. This 
approach has been used successfully to modify glucocere- 
brosidase so that it can be used as an enzyme replacement 
therapy for Gaucher’s disease, (an inherited deficiency). 
Glucocerebrosidase expressed in a mammalian system 
contains oligosaccharides terminating in sialic acids. But to 
target glucocerebrosidase to the mannose receptors of 
reticula-endothelial cells, where the enzyme function is 
required, the protein must have terminal mannose 
residues. To expose the mannosides, the glycoprotein is 
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Figure 2 
Glycoprotein remodelling of 
glucocerebrosidase for the treatment of 
Gaucher’s disease [8,91. For efficient 
targeting to the reticula-endothelial system, 
the oliaosaccharides found on 
gluco&ebrosidase made in tissue culture 
must be trimmed with glycosidases to expose 
mannoside residues. 
a-Sialidase 
b 
@Galactosidase 
e 
hexosamlnidasa 
trimmed with glycosidases (sialidase, galactosidase and 
hexosaminidase), as shown in Figure 2 [8,9]. 
It is also possible to add to the complexity of an oligo- 
saccharide using glycosyltransferases, which attach mono- 
saccharides in a regio- and stereo-selective manner to 
oligosaccharide sidechains. For example, pl,Cgalactosyl- 
transferase from bovine colostrum primarily recognizes ter- 
minal N-acetyl glucosaminide (GlcNAc) as an acceptor 
substrate and catalyzes the selective formation of the ter- 
minal Gal/31+4GlcNAc disaccharide sequence. Such enzy- 
matic in vitro synthesis is not limited to natural saccharides 
but can also be used for introducing labelled saccharides 
Figure 3 
into glycoproteins or to generate analogues. The recogni- 
tion process is often reasonably flexible, for instance, 
pl,4-galactosyltransferase can transfer galactose, glucose 
or iV-acetyl galactosamine to oligosaccharide chains ending 
in GlcNAc [lo]. 
Another important enzyme in the N-linked glycosylation 
pathway is oligosaccharyltransferase, which catalyses the 
glycosylation of asparagine residues on the nascent protein 
chain as it leaves the ribosome [ 1 l] (Fig. 3). This enzyme 
has been purified and can be obtained in large enough 
quantities for in vitro glycosylation studies of peptides con- 
taining asparagine sites for N-glycosylation. Glycosylation of 
The transfer of a tetradecasaccharide from a 
lipid precursor to the nascent polypeptide 
chain is a key step in the formation of 
N-linked oligosaccharides [121. 
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Figure 4 
HO 
OH 
Chemically synthesized undecapeptide 
containing O-linked N-acetyl glucosamine 
residues 1131. 
whole proteins has proved to be more difficult [12], 
however, except when the proteins are in a denatured state. 
Chemical synthesis of glycoproteins 
The chemical synthesis of glycopeptides has become pos- 
sible in recent years as milder deprotection methods have 
been developed for glycopeptide synthesis. Thus, it is now 
possible to incorporate glycosylated amino acids during 
solid-phase synthesis. This is particularly useful for small 
oligosaccharide sidechains, such as those found in O-linked 
glycans. A peptide that has recently been prepared by 
solid-phase peptide synthesis is shown in Figure 4 [13]. 
Alternatively, suitably protected peptides can be synthe- 
sized first, then chemically glycosylated. This is particularly 
useful for N-linked oligosaccharides, since the glycosyl 
amide linkage can be synthesized by coupling an aspartate 
sidechain of the peptide with easily available glycosylamines 
[ 141. Neither of these methods has been applied to chemical 
Figure 5 
NH-Lys-protein 
2 
HO 
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Neoglycoprotein linkages 1 1191, 2 1201 and 3 116,171. 
synthesis of large glycoproteins to date. But as the size limit 
for solid phase protein synthesis has now been extended to 
about 170 amino acids, the chemical synthesis of glycopro- 
teins such as erythropoietin (166 amino acids), an important 
glycoprotein hormone that is used in the treatment of 
anemia, should now be feasible. 
Chemical glycosylation methods are not restricted to the 
synthesis of natural glycoproteins but can also be used for 
generating ‘neoglycoproteins’, which contain unnatural link- 
ages between protein and saccharides, and are often chosen 
because they are more easy to synthesize [15]. Such glyco- 
sylation can dramatically improve the physical and biologi- 
cal properties of proteins. Neoglycoproteins have been 
synthesized by using the inherent reactivity of lysine and 
cysteine sidechains in proteins to achieve selective glycosy- 
lation. The resulting linkages are often structurally very dif- 
ferent from the natural linkage (such as linkages 1 and 2 in 
Figure S), and thus neoglycoproteins might have limited 
applications in structure-function studies but are useful as 
novel protein based therapeutics. They can also provide 
carbohydrate antigens and immunogens from which 
immunodiagnostic and therapeutic reagents can be derived. 
Some more native-like linkages (3) have recently been gen- 
erated by the reaction of glycosyl-N-iodoacetamides with 
cysteine residues [ 16,171. 
What next? 
The study of protein glycosylation integrates several disci- 
plines, including chemistry, biochemistry and molecular 
and cell biology. In the field of chemistry, recent advances 
in the organic synthesis of peptides and carbohydrates 
suggest that the total synthesis of glycoproteins could soon 
be possible, yielding homogeneous products of defined 
structure. Complementing such efforts, glycosyltrans- 
ferases and glycosidases have been studied intensively 
and can now be used either in cell culture or as isolated 
catalysts for glycoprotein synthesis. These chemical and 
enzymatic approaches should synergize; organic synthesis 
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can provide unnatural glycoproteins and can also supply 
suitable natural and unnatural substrates for the glycosyl- 
transferases and glycosidases. Where enzymes with the 
appropriate specificity exist and are available in sufficient 
quantities, enzymatic synthesis is faster and much more 
selective than chemical synthesis. We predict that, a prac- 
tical route to the synthesis of glycoproteins will probably 
involve a mixture of chemical and biological techniques. 
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